Greater endothelial activation, Weibel-Palade body release and host inflammatory response to plasmodium vivax, compared with plasmodium falciparum: A prospective study in Papua,Indonesia

Journal of Infectious Diseases

Volumn 202, Issue 1, 2010, Pages 109-112

  Yeo, Tsin W ^a,b   Lampah, Daniel A ^a   Tjitra, Emiliana ^c   Piera, Kim ^a   Gitawati, Retno ^c   Kenangalem, Enny ^a   Price, Ric N ^a,b,d   Anstey, Nicholas M ^a,b  

^a MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

^b ROYAL DARWIN HOSPITAL   (Australia)

^c NATIONAL INSTITUTE OF HEALTH RESEARCH AND DEVELOPMENT   (Indonesia)

^d JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN 2; ANTIMALARIAL AGENT; CYTOKINE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 6; SELE PROTEIN, HUMAN;

ADULT; ARTICLE; CELL ACTIVATION; CLINICAL TRIAL; FEMALE; HUMAN; INDONESIA; INFLAMMATION; MAJOR CLINICAL STUDY; MALARIA; MALARIA FALCIPARUM; MALE; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PLASMODIUM VIVAX MALARIA; PRIORITY JOURNAL; WEIBEL PALADE BODY; ANIMAL; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; METABOLISM;

ANIMALS; E-SELECTIN; GENE EXPRESSION REGULATION; HUMANS; INDONESIA; INFLAMMATION; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-10; INTERLEUKIN-6; MALARIA, FALCIPARUM; MALARIA, VIVAX; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; WEIBEL-PALADE BODIES;

EID: 77953716338     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/653211     Document Type: Article

References (15)

1. Price RN, Douglas NM, Anstey NM. New developments in Plasmodium vivax malaria: severe disease and the rise of chloroquine resistance. Curr Opin Infect Dis 2009; 22: 430-435.
2. Tjitra E, Anstey NM, Sugiarto P, et al. Multidrug-resistant Plasmodium vivax associated with severe and fatal malaria: a prospective study in Papua, Indonesia. PLoS Med 2008; 5: e128.
3. Genton B, D'Acremont V, Rare L, et al. Plasmodium vivax and mixed infections are associated with severe malaria in children: a prospective cohort study from Papua New Guinea. PLoS Med 2008; 5: e127.
4. Anstey NM, Russell B, Yeo TW, Price RN. The pathophysiology of vivax malaria. Trends Parasitol 2009; 25: 220-227.
5. Turner GD, Morrison H, Jones M, et al. An immunohistochemical study of the pathology of fatal malaria. Evidence for widespread endothelial activation and a potential role for intercellular adhesion molecule-1 in cerebral sequestration. Am J Pathol 1994; 145: 1057-1069. (Pubitemid 24345654)
6. Karunaweera ND, Wijesekera SK, Wanasekera D, Mendis KN, Carter R. The paroxysm of Plasmodium vivax malaria. Trends Parasitol 2003; 19: 188-193.
7. Hemmer CJ, Holst FG, Kern P, Chiwakata CB, Dietrich M, Reisinger EC. Stronger host response per parasitized erythrocyte in Plasmodium vivax or ovale than in Plasmodium falciparum. Trop Med Int Health 2006; 11: 817-823.
8. Yeo TW, Lampah DA, Gitawati R, et al. Angiopoietin-2 is associated with decreased endothelial nitric oxide and poor clinical outcome in severe falciparum malaria. Proc Natl Acad Sci U S A 2008; 105: 17097-17102.
9. Jakobsen PH, Morris-Jones S, Ronn A, et al. Increased plasma concentrations of sICAM-1, sVCAM-1 and sELAM-1 in patients with Plasmodium falciparum or P. vivax malaria and association with disease severity. Immunology 1994; 83: 665-669.
10. Ohnishi K. Serum levels of thrombomodulin, intercellular adhesion molecule-1, vascular cell adhesion molecule-1, and E-selectin in the acute phase of Plasmodium vivax malaria. Am J Trop Med Hyg 1999; 60: 248-250. (Pubitemid 29107110)
11. de Mast Q, Groot E, Asih PB, et al. ADAMTS13 deficiency with elevated levels of ultra-large and active von Willebrand factor in P. falciparum and P. vivax malaria. Am J Trop Med Hyg 2009; 80: 492-498.
12. Graninger W, Prada J, Neifer S, Zotter G, Thalhammer F, Kremsner PG. Upregulation of ICAM-I by Plasmodium falciparum: in vitro and in vivo studies. J Clin Pathol 1994; 47: 653-656.
13. Yeo TW, Lampah DA, Gitawati R, et al. Impaired nitric oxide bioavailability and L-arginine reversible endothelial dysfunction in adults with falciparum malaria. J Exp Med 2007; 204: 2693-2704. (Pubitemid 350044792)
14. Tripathi AK, Sha W, Shulaev V, Stins MF, Sullivan DJ Jr. Plasmodium falciparum-infected erythrocytes induce NF-kappaB regulated inflammatory pathways in human cerebral endothelium. Blood 2009; 114( 19): 4243-4252.
15. MacDonald SM, Bhisutthibhan J, Shapiro TA, et al. Immune mimicry in malaria: Plasmodium falciparum secretes a functional histaminereleasing factor homolog in vitro and in vivo. Proc Natl Acad Sci U S A 2001; 98: 10829-10832.